FDA-Drug2014-01-29Class II

IRBESARTAN, Tablet, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093746556.

Aidapak Services, LLC
Hazard

Labeling: Label Mixup: IRBESARTAN, Tablet, 150 mg may have potentially been mislabeled as the following drug: BENAZEPRIL HCL, Tablet, 40 mg, NDC 65162075410, Pedigree: AD32757_7, EXP: 5/13/2014.

Sold states
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Affected count
30 Tablets
Manufactured in
14301 Se 1st St, Vancouver, WA, United States
Products
IRBESARTAN, Tablet, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093746556.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-849-2014

Don't want to check this manually?

We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Get the Sunday Brief